Yale New Haven Health System adds virtual MSK care to its arsenal: We explore how its hybrid model of musculoskeletal care and treatment differs from other options on the market.
Digital health startups to watch: This week, we spotlight newly merged behavioral health VR company BehaVR and remote patient monitoring company Alio on the back of recent funding hauls.
What were Big Tech healthcare players up to in 2022? We review the most prominent healthcare developments from Big Tech entities in the past year and preview what’s on deck for 2023.
Big retail players jockey for healthcare positioning: We look back at noteworthy advancements made by retail health companies this year and how the top players stack up going into 2023.
Consumers want a one-stop-shop health management platform: But will diverse healthcare stakeholders band together to bring such a solution to market?
Employers are on the hook for more health benefits in 2023: We unpack new data and trends in employers’ struggle to keep employees healthy and happy.
There’s no place like home: Health systems are willing to treat patients in their homes, but barriers (namely staffing shortages and access to certified tech) still exist.
Reimbursement barriers impede remote patient monitoring growth: Health systems must prove their remote monitoring programs are effective—especially if they want state Medicaid programs to provide coverage.
Medical jargon even confuses English speakers: A JAMA Network Open study shows common medical terms carry the opposite meaning for patients. Providers and marketers, take note.
One healthcare prediction we got wrong for 2022: We look back over the year to see what didn’t happen, per our 2021 prognoses.
Healthcare predictions we got right for 2022: As we expected, the lines between healthcare and retail blurred, and consumers cozied up with connected health devices. We detail other predictions we got right for the year.
Disruption in the digital pharmacy space: We unpack developments with Medly, NowRx, and Mark Cuban Cost Plus Drugs and look ahead to what’s in store for 2023.
Assessing if digital therapies are evaluated fairly: A new report pushes for digital therapeutics to have their own standard of evidence. Do the authors have a valid argument?
Solving unmet food needs improves patients’ health: We predict food as medicine programs that demonstrate healthcare cost savings will generate more interest from providers and payers.
Easy access and short wait times drive consumers to telehealth: But virtual care providers will need to stay on top of their game to keep patients from going elsewhere.
Alexa, say it ain’t so: Amazon abruptly shuts down HIPAA-compliant third-party apps, but we think it could turn its voice assistant into a physician’s assistant.
Digital health startups to watch: This week, we spotlight tech-based managed services organization UpStream Healthcare and clinical trial services company Vial on the back of recent funding hauls.
Biotech firms suffer job cuts: Being in one of the biggest growth sectors in technology has not insulated the biotech sector during tech’s cold winter, but there are signs that it could be one of the first sectors to bounce back.
Thirty Madison goes into sleep mode: The D2C digital health company is quietly building a new vertical focused on sleep health—but the customer acquisition costs will be high
CVS and Walgreens reshape the role of pharmacists: We unpack recent moves both have made to address labor shortages, burnout, and other realities.